Sample client list
- Stelexis Therapeutics
- University of Pennsylvania
- Vayyar Imaging
Senior Partner at Pearl Cohen Zedek Latzer Baratz
Mark S Cohen is a founder of Pearl Cohen Zedek Latzer Baratz, senior partner, chair of the life sciences practice group and a member of the firm’s executive committee. Mr Cohen’s practice focuses on patent prosecution, opinions and commercial transactions in the pharmaceutical, chemical, biological and medical device sectors. He is well versed in all aspects of patent prosecution, IP management, strategic advice, technology transfer and licensing matters. His work includes management of large patent portfolios, negotiating terms, drafting agreements and counselling start-ups. He has been involved in large due diligence matters; infringement, validity and patentability opinions; licensing matters; and commercial transactions. His clients range from start-ups to Fortune 500 companies.
Mr Cohen was a board member of Masthercell Global Inc, a subsidiary of Orgenesis Inc (Nasdaq: ORGS), a manufacturer, service provider and developer of advanced cell therapies. Mr Cohen was also vice chair of the board and chair of the governance and nominating committee of Akari Therapeutics Plc (NASDAQ: AKTX), an emerging biopharmaceutical company that is developing anti-complement and anti-inflammatory molecules as life-transforming treatments for a wide range of severe and orphan autoimmune and inflammatory diseases.
Mr Cohen has published in Nature Biotechnology and various patent trade journals. He has lectured at the Practicing Law Institute and the American Conference Institute on general patent topics, and at other venues in the United States on patent issues in the biotechnology/pharmaceutical area. Mr Cohen was named by New York Metro Super Lawyers for 2019 as a Top-Rated Intellectual Property Lawyer in New York.
Mr Cohen recently represented Orgenesis in the sale of Masthercell Global, its contract development and manufacturing organisation subsidiary, for $315 million.